Martin Mielke
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria 9
- Immunology and Allergy top 2%
- Infectious Diseases top 2%
- Antimicrobial Resistance in Staphylococcus 9
- Clostridium difficile and Clostridium perfringens research 7
- Clinical Biochemistry top 1%
-
- Listeria monocytogenes in Food Safety 11
-
- Escherichia coli research studies 10
-
- Mycobacterium research and diagnosis 7
-
- Prion Diseases and Protein Misfolding 7
-
- Essential Oils and Antimicrobial Activity 7
- Co-authors
- Helmut HahnStefan EhlersRita BunikowskiHorst SkarabisWolfgang WitteKarsten BeckerAlex W. FriedrichBernhard Schwartländer
- Journals
- The Journal of Experimental Medicine (1 paper)SHILAP Revista de lepidopterología (1 paper)Blood (1 paper)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Martin Mielke
95 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 137
- Applied Microbiology and Biotechnology 180
- Molecular Medicine 317
- Immunology and Allergy 340
- Infectious Diseases 938
- Clinical Biochemistry 332
Countries citing papers authored by Martin Mielke
This map shows the geographic impact of Martin Mielke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Mielke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Mielke more than expected).
Fields of papers citing papers by Martin Mielke
This network shows the impact of papers produced by Martin Mielke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Mielke. The network helps show where Martin Mielke may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Martin Mielke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2023 | 6 | |
| 3 | 2021 | 103 | |
| 4 | 2019 | 3 | |
| 5 | 2018 | 2 | |
| 6 | How to deal with multidrug-resistant Gram-negative microorganisms in cross-border healthcare? Comparison of Dutch and German guidelines. | 2015 | 2 |
| 7 | 2015 | 16 | |
| 8 | 2013 | 4 | |
| 9 | 2013 | 50 | |
| 10 | 2012 | 35 | |
| 11 | 2011 | 39 | |
| 12 | Methicillin-resistant Staphylococcus aureus (MRSA) | 2010 | 4 |
| 13 | 2009 | 1 | |
| 14 | 2008 | 0 | |
| 15 | 2005 | 3 | |
| 16 | Rechtsgrundlagen zum Infektionsschutz im KrankenhausAnmerkungen für die Arbeitsmedizin | 2000 | 3 |
| 17 | 2000 | 240 | |
| 18 | 1998 | 12 | |
| 19 | 1989 | 74 | |
| 20 | 1988 | 13 |
About Martin Mielke
Martin Mielke is a scholar working on Endocrinology, Applied Microbiology and Biotechnology and Molecular Medicine, having authored 100 papers that have together received 3.1k indexed citations. Recurring topics across this work include Listeria monocytogenes in Food Safety (11 papers), Escherichia coli research studies (10 papers), Antimicrobial Resistance in Staphylococcus (9 papers), Antibiotic Resistance in Bacteria (9 papers), Mycobacterium research and diagnosis (7 papers), Prion Diseases and Protein Misfolding (7 papers), Essential Oils and Antimicrobial Activity (7 papers) and Clostridium difficile and Clostridium perfringens research (7 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (180 citations), Molecular Medicine (317 citations) and Immunology and Allergy (340 citations). Martin Mielke has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Helmut Hahn, Stefan Ehlers, Rita Bunikowski, Horst Skarabis, Wolfgang Witte, Karsten Becker, Alex W. Friedrich, Bernhard Schwartländer, W. Friedmann and Axel Schäfer. Their work appears in journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.